Isabelle Girault

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

Asier Sáez‐Cirión, Charline Bacchus, Laurent Hocqueloux et al. · PLoS Pathogens · 2013 · 983 citations · Full text

Viral Persistence, Functional Hiv Cure, Combination Antiretroviral Therapy +15

eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies

Lise Boussemart, Hélène Malka-Mahieu, Isabelle Girault et al. · Nature · 2014 · 352 citations

Oncology, Anti-mek Cancer Therapies, Medicine +9

Translational control of tumor immune escape via the eIF4F–STAT1–PD-L1 axis in melanoma

Michaël Cerezo, Ramdane Guemiri, Sabine Druillennec et al. · Nature Medicine · 2018 · 248 citations

Cancer Immunosurveillance, Eif4f–stat1–pd-l1 Axis, Medicine +12

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

Assia Asrir, Claire Tardiveau, Juliette Coudert et al. · Cancer Cell · 2022 · 234 citations · Full text

Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection

Anne-Sophie Liovat, Marie-Anne Rey-Cuillé, Camille Lécuroux et al. · PLoS ONE · 2012 · 146 citations · Full text

Disease Progression, Immunodeficiencies, T-regulatory Cell +23